This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Understand the key moments to prioritize paying off debt versus investing. Optimize your financial strategy for success!
28,655 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
New documents reveal Epstein used elite ties to influence major philanthropy groups, raising questions about governan...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...
Galaxy Digital lowers its odds on the CLARITY Act, putting clarity chances passage this year at 60% as lawmakers rush...
Original Medicare covers your doctor bills after the deductible, but the 20% coinsurance has no cap. As costs rise, r...
Grab's stock move mirrors a broader tech and regional risk beat. As Uber's board change unfolds, investors weigh grow...
Lauren Sánchez Bezos is fueling a $34 million Bezos Earth Fund push to reinvent fabrics—from bacteria-grown fibers to...
eXp Realty unveils a new division to help agents break into the new construction market. The program aims to close th...
Michigan lawmakers weigh Gov. Whitmer's housing package, drawing on Austin's reforms as a potential road map. Advocat...
A civil social-media debate this spring highlighted a looming fight over who will own payments: Visa or on-chain stab...
SpaceX is pursuing a bold, trillion-dollar plan to become the backbone of global connectivity. As markets watch, inve...
Investors face a pivotal choice: put $10,000 into Nvidia's AI compute surge or Meta's ad-driven AI expansion. Here's ...